Susan B. Liu

1.2k total citations
9 papers, 971 citations indexed

About

Susan B. Liu is a scholar working on Hepatology, Molecular Biology and Epidemiology. According to data from OpenAlex, Susan B. Liu has authored 9 papers receiving a total of 971 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hepatology, 4 papers in Molecular Biology and 3 papers in Epidemiology. Recurrent topics in Susan B. Liu's work include Liver physiology and pathology (5 papers), Liver Disease Diagnosis and Treatment (3 papers) and Liver Diseases and Immunity (3 papers). Susan B. Liu is often cited by papers focused on Liver physiology and pathology (5 papers), Liver Disease Diagnosis and Treatment (3 papers) and Liver Diseases and Immunity (3 papers). Susan B. Liu collaborates with scholars based in United States, Germany and China. Susan B. Liu's co-authors include Deanna Sverdlov, Yury Popov, Naoki Ikenaga, Zhenwei Peng, Detlef Schuppan, Victoria Smith, Shuhei Yoshida, Kahini A. Vaid, Detlef Schuppan and Amanda Mikels‐Vigdal and has published in prestigious journals such as Nature Biotechnology, Gastroenterology and Hepatology.

In The Last Decade

Susan B. Liu

9 papers receiving 961 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan B. Liu United States 9 443 384 339 229 138 9 971
Lishuai Qu China 19 304 0.7× 376 1.0× 497 1.5× 88 0.4× 106 0.8× 48 1.0k
Hidenobu Kojima Japan 16 255 0.6× 118 0.3× 256 0.8× 374 1.6× 110 0.8× 38 801
Philipp‐Sebastian Koch Germany 16 182 0.4× 156 0.4× 348 1.0× 141 0.6× 217 1.6× 35 948
Jiefu Huang China 16 315 0.7× 291 0.8× 367 1.1× 203 0.9× 160 1.2× 57 988
Shunli Shen China 22 480 1.1× 305 0.8× 434 1.3× 336 1.5× 508 3.7× 58 1.4k
Lin Zhong China 15 254 0.6× 254 0.7× 235 0.7× 74 0.3× 341 2.5× 59 1.0k
Takehiro Hayashi Japan 15 279 0.6× 178 0.5× 394 1.2× 125 0.5× 333 2.4× 44 937
Felice Marinosci Italy 16 265 0.6× 191 0.5× 413 1.2× 59 0.3× 273 2.0× 24 1.0k

Countries citing papers authored by Susan B. Liu

Since Specialization
Citations

This map shows the geographic impact of Susan B. Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan B. Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan B. Liu more than expected).

Fields of papers citing papers by Susan B. Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan B. Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan B. Liu. The network helps show where Susan B. Liu may publish in the future.

Co-authorship network of co-authors of Susan B. Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Susan B. Liu. A scholar is included among the top collaborators of Susan B. Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan B. Liu. Susan B. Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Peng, Zhenwei, Sonja Rothweiler, Guangyan Wei, et al.. (2017). The ectonucleotidase ENTPD1/CD39 limits biliary injury and fibrosis in mouse models of sclerosing cholangitis. Hepatology Communications. 1(9). 957–972. 29 indexed citations
2.
Ikenaga, Naoki, Zhenwei Peng, Kahini A. Vaid, et al.. (2017). Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal. Gut. 66(9). 1697–1708. 219 indexed citations
3.
Liu, Susan B., Naoki Ikenaga, Zhenwei Peng, et al.. (2015). Lysyl oxidase activity contributes to collagen stabilization during liver fibrosis progression and limits spontaneous fibrosis reversal in mice. The FASEB Journal. 30(4). 1599–1609. 171 indexed citations
4.
Peng, Zhenwei, Naoki Ikenaga, Susan B. Liu, et al.. (2015). Integrin αvβ6 critically regulates hepatic progenitor cell function and promotes ductular reaction, fibrosis, and tumorigenesis. Hepatology. 63(1). 217–232. 99 indexed citations
5.
Ikenaga, Naoki, Susan B. Liu, Deanna Sverdlov, et al.. (2014). A New Mdr2−/− Mouse Model of Sclerosing Cholangitis with Rapid Fibrosis Progression, Early-Onset Portal Hypertension, and Liver Cancer. American Journal Of Pathology. 185(2). 325–334. 68 indexed citations
6.
Yoshida, Shuhei, Naoki Ikenaga, Susan B. Liu, et al.. (2014). Extrahepatic Platelet-Derived Growth Factor-β, Delivered by Platelets, Promotes Activation of Hepatic Stellate Cells and Biliary Fibrosis in Mice. Gastroenterology. 147(6). 1378–1392. 131 indexed citations
7.
Kuramitsu, Kaori, Deanna Sverdlov, Susan B. Liu, et al.. (2013). Failure of Fibrotic Liver Regeneration in Mice Is Linked to a Severe Fibrogenic Response Driven by Hepatic Progenitor Cell Activation. American Journal Of Pathology. 183(1). 182–194. 91 indexed citations
8.
Kwong, Gabriel A., Geoffrey von Maltzahn, Gayathree Murugappan, et al.. (2012). Mass-encoded synthetic biomarkers for multiplexed urinary monitoring of disease. Nature Biotechnology. 31(1). 63–70. 12 indexed citations
9.
Maltzahn, Geoffrey von, Gayathree Murugappan, Steven Mo, et al.. (2011). Mass-encoded synthetic biomarkers for multiplexed urinary monitoring of disease. DSpace@MIT (Massachusetts Institute of Technology). 151 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026